Searched for
EQT LIFE SCIENCES
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...- EQT Partners lines up $1 billion CitiusTech exitEQT Partners is gearing up to divest its substantial 40% interest in CitiusTech, aiming to secure close to $1 billion. The Swedish investme...
- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Swedish PE firm EQT plans Rs 4,000 crore IPO for StraiveStraive specialises in helping clients leverage data, insights, knowledge, and AI-driven solutions. The company's clientele spans sectors, ...
- Herd on PE Street: TPG outruns everyone in race for AltimetrikLast month, its Asia-focused fund TPG Asia VIII secured $5.3 billion in aggregate capital commitments. That made it the firm’s largest Asia...
- General Atlantic, TPG Capital, two other PEs in race for AltimetrikAltimetrik has offices in over 20 locations, six of them in India, with more than 80% of its workforce based in the country. The company ha...
- KKR acquires Healthium from Apax Partners for Rs 7,000 crKKR acquired Healthium Medtech Ltd., a leading Indian medical devices company, from Apax Partners. The deal, valued at approximately Rs 700...
- KKR to buy Healthium Medtech for Rs 7000 cr from ApaxBinding agreement signed; formal announcement by early next week, pips rival bidders Mankind Pharma-Chrys Cap Healthium is the largest manu...
- Mubadala plans big deals in India's healthcare spaceAbu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a f...
- Novo Nordisk owner joins the race for Healthium MedtechNovo Holdings is the latest challenger in a hotly contested bidding process for Healthium, 99.8% owned by Apax Partners. Buyout funds KKR, ...
- AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolioAstraZeneca announced its acquisition of Amolyt Pharma, a company focused on endocrine diseases, for $1.05 billion in cash. This move aims ...
- KKR, Carlyle and EQT among five buyout funds in race for HealthiumKKR, Carlyle, EQT, Hillhouse, and TA Associates are competing to acquire Healthium Medtech, the largest homegrown surgical sutures and surg...
- Sonia Dasgupta on three significant trends in the private equity market in 2023Emergence of the Healthcare sector: India has seen an increase in investments in the hospitals/healthcare sector (Rs 39,000 crore)in 2023 a...
- Blackstone among global funds in race for Sai LifeSeveral global funds, including Blackstone, Carlyle, PAG, CVC Capital, BPEA EQT, Brookfield Asset Management, and Apax Partners, are intere...
- Bain & Able: PE edges past rivals for CitiusTech stakeIf successful, this would be the second investment by the Boston-headquartered PE group in as many months in India, after having bought int...
Load More
